Efficacy of CI-1020, an endothelin-A receptor antagonist, in hypoxic pulmonary hypertension

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Haleen, Stephen ^a   Schroeder, Richard ^a   Walker, Donnelle ^a   Quenby Brown, Edie ^a   Welch, Kathleen ^a   Hallak, Hussein ^a   Uprichard, Andrew ^a   Keiser, Joan ^a  

^a PFIZER INC   (United States)

Author keywords

CI 1020; ETA antagonist; Hypoxia; Pulmonary hypertension

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR;

ANIMAL; ANOXIA; ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOMEGALY; CHRONIC DISEASE; DRUG ANTAGONISM; DRUG EFFECT; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANOXIA; BLOOD PRESSURE; CARDIOMEGALY; CHRONIC DISEASE; DIOXOLES; ENDOTHELIN-1; HYPERTENSION, PULMONARY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN;

EID: 0031630062     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00092     Document Type: Article

References (8)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Haleen S, Cheng X-M. Cardiopulmonary indications of endothelin inhibitors: a review of recent efficacy studies. Exp Opin Invest Drugs 1997;6:475-87.
3. Reynolds E, Keiser J, Haleen S, et al. Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist. J Pharmacol Exp Ther 1995;273:1410-7.
4. Keiser J, Schroeder R, Walker D, et al. The effects of PD 156707 in acute, hypoxic pulmonary hypertension in the rat [Abstract]. FASEB J 1997;2:A26.
5. Rabinovitch M, Gamble WJ, Nadas AS, et al. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 1979;236:H818-27.
6. DiCarlo V, Chen S-J, Meng Q, et al. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am J Physiol 1995;269:L690-7.
7. Chen S-J, Chen Y-F, Opgenorth T, et al. The orally active non-peptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. J Cardiovasc Pharmacol 1997;29:713-25.
8. Chen S-J, Chen Y-F, Meng Q, et al. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. Am J Physiol 1995;79:H2122-31.